Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Frieman

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2021
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild InfectionOluwasanmi O Adenaiye, Jianyu Lai, P Jacob Bueno de Mesquita, et al.
Molecular Therapy. Nucleic Acids|August 29, 2022
Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activityLonglong Si, Haiqing Bai, Crystal Yuri Oh, et al.
Plos Computational Biology|May 5, 2023
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patientsMegan M Sperry, Tomiko T Oskotsky, Ivana Marić, et al.
Journal of Extracellular Vesicles|November 19, 2024
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Cell|February 12, 2022
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicityFrancesco Borriello, Valentina Poli, Ellen Shrock, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2021
Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild InfectionOluwasanmi O Adenaiye, Jianyu Lai, P Jacob Bueno de Mesquita, et al.
Molecular Therapy. Nucleic Acids|August 29, 2022
Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activityLonglong Si, Haiqing Bai, Crystal Yuri Oh, et al.
Plos Computational Biology|May 5, 2023
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patientsMegan M Sperry, Tomiko T Oskotsky, Ivana Marić, et al.
Journal of Extracellular Vesicles|November 19, 2024
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, et al.
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktailJinhui Dong, Seth Zost, Allison Greaney, et al.
ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.
NPJ Vaccines|January 17, 2026
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59Linda Earnest, Daniel Fernandez Ruiz, Melissa A Edeling, et al.
Cell|February 12, 2022
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicityFrancesco Borriello, Valentina Poli, Ellen Shrock, et al.
Pageof 6